163 related articles for article (PubMed ID: 8235707)
1. Chronic myelogenous leukemia: progress in chemotherapy and evaluation of prognostic score 1. The German CML Study Group.
Hehlmann R; Ansari H; Hasford J; Heimpel H
Semin Hematol; 1993 Jul; 30(3 Suppl 3):44-8. PubMed ID: 8235707
[No Abstract] [Full Text] [Related]
2. New perspectives with interferon alpha. The German CML study group experience.
Hehlmann R; Ansari H; Adelberger V; Heinze B; Hossfeld K; Hochhaus A; Heimpel H
Bone Marrow Transplant; 1994; 14 Suppl 3():S14-20. PubMed ID: 7697004
[No Abstract] [Full Text] [Related]
3. Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study Group.
Hehlmann R; Heimpel H; Griesshammer M; Kolb HJ; Heinze B; Hossfeld DK; Wickramanayake PD; Essers U; Thiele J; Georgii A
Leukemia; 1992; 6 Suppl 3():110S-114S. PubMed ID: 1602805
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic progress and comparative aspects in chronic myelogenous leukemia (CML): interferon alpha vs. hydroxyurea vs. busulfan and expression of MMTV-related endogenous retroviral sequences in CML. German CML Study Group.
Hehlmann R; Kister P; Willer A; Simon M; Schenk M; Seifarth W; Papakonstantinou G; Saussele S; Kolb HJ; Ansari H
Leukemia; 1994 Apr; 8 Suppl 1():S127-32. PubMed ID: 8152279
[TBL] [Abstract][Full Text] [Related]
5. Treatment choices in chronic myelogenous leukemia.
Ready N; Freeman NJ; Carvalho A
Hosp Pract (Off Ed); 1992 Sep; 27(9A):95-8, 101. PubMed ID: 1522171
[No Abstract] [Full Text] [Related]
6. Approaches to the treatment of chronic myeloid leukemia.
Savage DG; Goldman JM
Int J Hematol; 1994 Jul; 60(1):1-21. PubMed ID: 7919235
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.
Hehlmann R; Heimpel H; Hasford J; Kolb HJ; Pralle H; Hossfeld DK; Queisser W; Löffler H; Hochhaus A; Heinze B
Blood; 1994 Dec; 84(12):4064-77. PubMed ID: 7994025
[TBL] [Abstract][Full Text] [Related]
8. The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1.
Hehlmann R; Heimpel H; Kolb HJ; Heinze B; Hochhaus A; Griesshammer M; Pralle H; Queisser WP; Essers U; Falge C
Leuk Lymphoma; 1993; 11 Suppl 1():159-68. PubMed ID: 8251890
[TBL] [Abstract][Full Text] [Related]
9. [The analysis of failures in the treatment of children with chronic myelocytic leukemia in the studies of Polish pediatric leukemia/ lymphoma group].
Chybicka A; Bogusławska-Jaworska J; Kałwak K; Turkiewicz D; Armata J; Balcerska A; Cwiklińska M; Hicke-Roberts A; Kaczmarek-Kanold M; Kołecki P; Kowalczyk J; Krauze A; Matysiak M; Płoszyńska A; Rokicka-Milewska R; Sońta-Jakimczyk D; Sikorska-Fic B; Wiśniewska-Slusarz H; Wysocki M; Wachowiak J
Wiad Lek; 1998; 51 Suppl 4():33-9. PubMed ID: 10731941
[TBL] [Abstract][Full Text] [Related]
10. Update on therapy for chronic myelogenous leukemia.
Weinberger BB
J La State Med Soc; 1994 Aug; 146(8):341-3. PubMed ID: 7930864
[TBL] [Abstract][Full Text] [Related]
11. [Chronic myeloid leukemia. State of the art, May 1993].
Hehlmann R
Schweiz Med Wochenschr; 1994 Jan; 124(1-2):37-43. PubMed ID: 8296189
[TBL] [Abstract][Full Text] [Related]
12. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
[TBL] [Abstract][Full Text] [Related]
13. [Chronic myeloid leukemia: current pathogenetic aspects and new therapeutic approaches (a foreign literature review)].
Petukhov VI; Strozha IL; Bondare DK
Ter Arkh; 2001; 73(12):96-101. PubMed ID: 11858124
[No Abstract] [Full Text] [Related]
14. [The assessment of therapeutic success in chronic myeloid leukemia].
Griesshammer M; Hehlmann R; Heimpel H
Dtsch Med Wochenschr; 1995 Apr; 120(17):620-5. PubMed ID: 7537652
[No Abstract] [Full Text] [Related]
15. [Clinical study of chronic myelogenous leukemia].
Shibata A
Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1318-30. PubMed ID: 8245626
[No Abstract] [Full Text] [Related]
16. [Interferon-alpha in the treatment of patients with chronic myeloid leukemia].
Faber E; Jarosová M; Divoký V; Luhový M; Komenda S; Sulovská I; Hubácek J; Slezák P; Papajik T; Raida L; Heczko M; Indrák K
Vnitr Lek; 1997 Jan; 43(1):13-7. PubMed ID: 9221559
[TBL] [Abstract][Full Text] [Related]
17. [Interferon-alpha in the treatment of chronic myeloid leukemia].
Guilhot F
Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
[No Abstract] [Full Text] [Related]
18. [Chronic myeloid leukemia].
Hehlmann R
Ther Umsch; 1996 Feb; 53(2):82-7. PubMed ID: 8629268
[TBL] [Abstract][Full Text] [Related]
19. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group.
J Natl Cancer Inst; 1997 Nov; 89(21):1616-20. PubMed ID: 9362160
[TBL] [Abstract][Full Text] [Related]
20. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
